Navigation Links
Breast cancer incidence among Iraqi women profiled
Date:3/10/2010

DEAD SEA, Jordan Breast cancer continues to rise in Iraq, and scientists have established the Iraqi National Cancer Research Program to better understand the underlying molecular and environmental causes in an effort to curb the incidence of cancer.

"Breast cancer is the most common type of malignancy recorded in the cancer registries of almost all countries within the Eastern Mediterranean Region. In Iraq, the continuous rise in the incidence rate is associated with an obvious trend to affect premenopausal women," said Nada A.S. Alwan, M.D., Ph.D., director of the National Breast Cancer Research Unit at Baghdad University Medical College and the executive director of the newly established Iraqi National Cancer Research Program.

Alwan presented early data at the second AACR Dead Sea International Conference on Advances in Cancer Research: From the Laboratory to the Clinic, held March 7-10, 2010.

The Iraqi National Cancer Research Program was organized by the Iraqi minister of higher education and scientific research in 2009 in collaboration with the common secretariat for the Council of Ministers and the Iraqi Parliament.

"This project includes within its objectives comprehensive epidemiologic studies on risk factors of the main encountered cancers in Iraq, with a focus on the characteristics and behaviors of cancer in patients inhabiting different geographic areas," said Alwan.

The current study focused on 721 of 5,044 women who complained of breast lumps later diagnosed as cancer. Approximately one-third of the diagnosed patients were between 40 and 49 years old; 71.9 percent came from urban areas and 75 percent were married.

History of lactation was reported in 63.1 percent of the women and 29 percent had taken hormone therapy. A family history of breast cancer was reported in 16.2 percent of cases.

Although 90.6 percent of women detected a lump on self-examination, only 32 percent sought medical advice within the first month. Because of this, 47 percent of them presented with advanced stage breast cancer, either stage III or IV cancer. The main histological type was invasive ductal carcinoma of grade 2 in 56.6 percent and grade 3 in 39.9 percent. Estrogen-receptor positive tumors were noted in 65.1 percent of the cases and progesterone-receptor positive tumors were noted in 45.1 percent of the cases.

"We are currently planning to use this information to compare the demographic characteristics, clinicopathological presentations and management outcomes of breast cancer patients within selected countries in the Middle East," said Alwan.


'/>"/>

Contact: Jeremy Moore
jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Related medicine news :

1. MRI finds tumors in second breast of women diagnosed with cancer in one breast, Mayo researchers say
2. Most early stage breast cancer patients may not need radiation after mastectomy
3. Breastfeeding protects children against peptic ulcer bacterium
4. Breast Cancer Patients Often Confused by Genomic Testing
5. Khanna and Stephen Baldwin Attend Carol M. Baldwin Breast Cancer Research
6. Most early-stage breast cancer patients may not need radiation after mastectomy
7. Breast-Feeding Helps Mom Stay Slimmer Later in Life
8. Freezing Technique May Stop Breast Cancer
9. Certain Bone Drugs May Lower Breast Cancer Risk
10. Acupuncture may relieve joint pain caused by some breast cancer treatments
11. Radiation Most Effective Soon After Breast Cancer Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... ... April 28, 2016 , ... Trinity ... Tobacco-Free Kids, a leading force in the fight to reduce tobacco use and ... policies that can help reduce tobacco use. The initiative brings together two organizations ...
(Date:4/28/2016)... Illinois (PRWEB) , ... April ... ... the leading provider of enterprise Data Center Infrastructure Management solutions, announces today ... focuses on feature enhancements in the area of capacity management and optimization, ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... Aesthetic Surgery Education and Anzu®, developers of the AnzuMedical™ Knowledge Sharing and ... Surgery Collaborative Residency Network. The platform is scheduled to launch in July 2016 ...
(Date:4/28/2016)... ... April 28, 2016 , ... Accreditation Commission ... Oncology Pharmacy Association (COPA) to develop a comprehensive Specialty Pharmacy Accreditation with Distinction ... an accreditation distinction. ACHC provides a wide range of pharmacy accreditation services that ...
(Date:4/28/2016)... D.C. (PRWEB) , ... April 28, 2016 , ... The ... and Prevention (CDC) has established an ICD-10-CM code for sarcopenia, giving it recognition for ... the medical community effective October 1, 2016. , Sarcopenia is defined as a combination ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 2016 , Net Sales of $1.90 billion ... the prior year period, and an increase of 1.2% on ... EPS for the first quarter were $0.52 reported, a decrease ... an increase of 29.9% over the prior year period ... guidance for 2016 Zimmer Biomet Holdings, Inc. (NYSE ...
(Date:4/28/2016)... , April 28, 2016 TapImmune,Inc. ... of innovative peptide and gene-based immunotherapeutics and vaccines for the ... be presenting at the 3rd Annual Growth Capital Expo ... th , 2016 at Caesars Palace in Las Vegas, Nevada.  ... on Wednesday, May 4 th by Dr. John ...
(Date:4/27/2016)... --   , Total Sales ... Sales  Clinical sales grow 16% year-over-year  , ... OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal laser ... quarter ended March 31, 2016 and provided an update ... strategy. First Quarter 2016 Revenue Results by ...
Breaking Medicine Technology: